To conclude, LAG-3 may mark a small subset of IL-10-positive T cells but in the context of a depleting mAb, we expect a dominant role for pathogenic IL-10lo LAG-3+ T cells in IBD. This evidence concerns the gene IL10 and inflammatory bowel disease.